skip to Main Content

STRIVING TOWARDS THE ELIMINATION OF HCV INFECTION

02-03 February 2018

Berlin, Germany

Prof. Francesco Negro, Switzerland

Francesco Negro is Professor at the Departments of Specialty Medicine and of Pathology and Immunology of the University of Geneva, Switzerland. He is also Founder and Chairman of the Swiss Hepatitis C Cohort Study, Co-Editor of Liver International, and Educational Councilor of the European Association for the Study of the Liver.

Professor Negro earned his medical degree in 1982 and was board-certified in Gastroenterology in 1986 at the University of Torino, Italy. He undertook post-doctoral training at the Division of Molecular Virology and Immunology, Georgetown University, USA, and at the Hepatitis Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA, between 1986 and 1989. Professor Negro analysed hepatitis C virus (HCV) replication at the tissue level using several distinct approaches, establishing anatomo-clinical correlations. His studies led him to associate HCV genotype 3a with a particular form of severe liver steatosis, and to analyse the mechanisms thereof.

More recently, Professor Negro’s work has focused on the pathogenesis of extrahepatic manifestations associated with HCV, and, particularly, on the mechanisms leading to glucose metabolism alterations, such as insulin resistance and diabetes, and on the epidemiology of HCV. He has participated in several clinical trials in acute and chronic HCV and has authored or co-authored more than 270 peer-reviewed manuscripts in the field of hepatology, and his h-index is 55. He serves in the updating committees of the clinical practice guidelines for HCV of the EASL and the World Health Organisation.

Read more

Prof. Alessio Aghemo, Italy

Prof. Alessio Aghemo (MD, PhD) received his medical degree from the University of Milan in 2001, where he also specialized in gastroenterology and later completed his post-doctoral research in gastroenterology by studying the mechanisms of Ribavirin induced anemia in patients with chronic hepatitis C.

He served as the director of the hepatology outpatients clinic at the Gastroenterology and Hepatology Unit at the Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, University of Milan, until 2017. In 2017 he was appointed Associate Professor of Gastroenterology at the Humanitas University where he is the Head of The Hepatitis Center. Prof. Aghemo is currently involved in many national and international clinical trials on the treatment of chronic Hepatitis C virus infection. He has contributed to the Italian and European clinical practice guidelines on the management and treatment of patients with chronic hepatitis C.
Read more

Prof. Jason Grebely, Australia

Prof. Jason Grebely is an Associate Professor and NHRMC Career Development Fellow in the Viral Hepatitis Clinical Program at the Kirby Institute, UNSW Australia. Jason completed his BSc in Biochemistry and Molecular Biology and his PhD in Pharmacology at the University of British Columbia in Vancouver, Canada. He then completed a Post Doctoral Fellowship in Clinical Epidemiology at UNSW Australia.

Jason’s research has contributed to understanding the epidemiology and natural history of HCV; evidence supporting the care of HCV among PWID; the development of international recommendations for the management of HCV among PWID; and has informed state-based, national, and international strategies for viral hepatitis.
Read more